Miracle cure: Wockhardt’s experimental drug defeats deadly superbug in dramatic recovery
Wockhardt Limited announced that its investigational drug Zaynich (Zidebactam/Cefepime) has successfully treated a complex case of bacterial meningitis caused by a pan-drug-resistant superbug under compassionate use. This breakthrough marks another instance where the novel antibiotic has proven its efficacy against critical infections, particularly those caused by multi-drug-resistant bacteria. The patient, a 64-year-old man with Type […]